Advancing RSV Maternal Immunization: A Gap Analysis Report

This report and associated brief describe the evidence and policy needs of global and country decision-makers, public health program planners, and implementers that may be involved in maternal respiratory syncytial virus (RSV) vaccine decisions or delivery. Developed by the Advancing Maternal Immunization collaboration, a group of cross-sectoral experts convened by PATH and the World Health Organization to advance RSV maternal immunization, the report focuses specifically on the context of potential introduction in low- and middle-income countries (LMICs) and summarizes relevant evidence across the following broad topic areas: 1) disease, 2) product, 3) health economics and financing, and 4) vaccine service delivery. Critical gaps in evidence are highlighted that, if left unfilled, could delay or preclude vaccine introduction in LMICs.

Author: Advancing Maternal Immunization collaboration

Published: 2018

» Download file: Report (English)

1.6 MB PDF (Located at

» Download file: Brief (English)

839.8 KB PDF (Located at

Resource types: Report, PATH resource

Diseases/vaccines: Respiratory syncytial virus (RSV)

Topics: Advocacy and communications, Introduction and service delivery, Immunization financing, Organizations and coalitions, Disease burden and surveillance, Vaccine safety and performance, Disease/vaccine specific information, Supply chain and logistics systems

Regions: Global